Dowsett’s algorithm was recently published in npj Breast Cancer, a Nature Partner Journal supported by the Breast Cancer Research Foundation. It is intended to help physicians triage postmenopausal women with ER+ HER2–breast cancers, which represent around 70% of breast cancer cases.1 During the pandemic, many within this patient group were prescribed neoadjuvant endocrine therapy (NeoET), rather than surgery, as a disease management strategy.
Analysis of biomarkers in biopsies helps identify breast cancer patients in need of urgent surgery or chemotherapy during COVID-19 pandemic.